Samarth Kulkarni
2018
In 2018, Samarth Kulkarni earned a total compensation of $9.7M as Chief Executive Officer at CRISPR Therapeutics AG, a 40% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $362,250 |
|---|---|
| Option Awards | $8,841,073 |
| Salary | $514,583 |
| Other | $9,625 |
| Total | $9,727,532 |
Kulkarni received $8.8M in option awards, accounting for 91% of the total pay in 2018.
Kulkarni also received $362.3K in non-equity incentive plan, $514.6K in salary and $9.6K in other compensation.
Rankings
In 2018, Samarth Kulkarni's compensation ranked 724th out of 14,244 executives tracked by ExecPay. In other words, Kulkarni earned more than 94.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 724 out of 14,244 | 95th |
Division Manufacturing | 236 out of 5,765 | 96th |
Major group Chemicals And Allied Products | 66 out of 2,128 | 97th |
Industry group Drugs | 50 out of 1,817 | 97th |
Industry Biological Products, Except Diagnostic Substances | 14 out of 339 | 96th |
Source: SEC filing on April 30, 2019.
Kulkarni's colleagues
We found four more compensation records of executives who worked with Samarth Kulkarni at CRISPR Therapeutics AG in 2018.
News
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2021 pay jumps 87% to $17M
April 25, 2022
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2020 pay falls 44% to $9.1M
April 28, 2021
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2019 pay jumps 67% to $16M
April 24, 2020
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2018 pay jumps 40% to $9.7M
April 30, 2019